Document is current
Any future updates will be listed below
-
Authors
Beauchamp, Erwan
Gamma, Jay M.
Cromwell, Christopher R.
Moussa, Eman W.
Pain, Rony
Kostiuk, Morris A.
Acevedo-Morantes, Claudia
Iyer, Aishwarya
Yap, Megan
Vincent, Krista M.
Postovit, Lynne M.
Julien, Olivier
Hubbard, Basil P.
Mackey, John R.
Berthiaume, Luc G. https://orcid.org/0000-0003-0926-059X
-
Funding
Funding for this research was provided by:
Alberta Cancer Foundation (26362, 26927)
Eusera
Pacylex Pharmaceuticals Inc.
Alberta Innovates - Health Solutions (Translational Health Chair)
Dr Heleen and Rod McLeod through the Cancer Research Institute of Northern Alberta
- License Information
-
More Information
Article History
Received: 13 November 2023
Accepted: 31 March 2024
First Online: 7 May 2024
Declarations
:
: All procedures performed in this study involving animals or human participants were in accordance with the ethical standards of the University of Alberta Institutional Animal and Human Research Ethics Committees and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: As co-founders and/or shareholders of Pacylex Pharmaceuticals Inc. (), which owns the rights to patent applications PCT/2012/000696 and PCT/2013/050821, L.G.B., J.R.M., E.B., J.M.G., R.P. and M.Y. declare potential competing interests.
